You are here: Industry Insights > GlobalData

News List

COVID-19 has fast-tracked digital transformation timeline for pharma industry: GlobalData expresspharma
March 05, 2021
Even though the pharma sector used to display a more conservative stance toward the adoption of new technologies, the COVID-19 pandemic acted as a trigger that forced the pharma sector to accelerate the digital transformation timeline, says GlobalData.
Launch of generic brands for expensive oncology drugs improves treatment affordability and access in India- GlobalData expresspharma
March 04, 2021
As per India’s National Cancer Registry Programme, the estimated number of people living with cancer in 2020 was around 2.25 million.
Brexit deal offers UK access to research and innovation program worth €95.5 bn: GlobalData expresspharma
February 20, 2021
The UK-EU trade deal will give the UK researchers and businesses access to Horizon Europe funding on equivalent terms as EU counterparts, including eligibility to lead projects.
Vaccine trials essential to evaluate effectiveness against new COVID-19 variants: GlobalData expresspharma
February 10, 2021
The largest proportion of the ongoing vaccine trials are now in Phase II (38.6 per cent) and Phase III (36.3 per cent), after Phase I studies dominated the earlier period of the pandemic.
COVID-19 clinical trials have risen by 639 percent, says report europeanpharmaceuticalreview
February 03, 2021
New findings have shown that there are currently over 4,000 clinical trials taking place investigating potential COVID-19 therapies.
AI to be most transformative technology for pharma, finds survey europeanpharmaceuticalreview
February 01, 2021
A new report suggests artificial intelligence (AI) will be the most disruptive technology in the pharmaceutical industry this year and beyond.
mRNA COVID-19 vaccine approvals likely to increase development and approvals in oncology: GlobalData expresspharma
February 01, 2021
The rapid advancement of mRNA vaccine development in recent months – in an attempt to halt the COVID-19 pandemic – is expected to continue to break barriers in the pharma industry, with the oncology market being the most likely to benefit, says GlobalData
J&J’s COVID-19 vaccine best used to curb outbreak, Novavax’s vaccine for overall protection: GlobalData expresspharma
February 01, 2021
As countries increasingly have weapons against COVID-19 in their armamentarium, increased scrutiny will be placed on the fifth, sixth, and later vaccines to enter the market.
Misinformation, future of work among key pharma trends in 2021: GlobalData expresspharma
January 27, 2021
The pharma industry will be shaped by several emerging trends in 2021. The industry will need to adapt quickly post-COVID-19 by overcoming the spread of online misinformation and preparing for a new way of working, says GlobalData.
AI to be most disruptive technology across pharma industry in 2021 and beyond expresspharma
January 25, 2021
GlobalData analysis shows that while four partnerships were forged between AI vendors and large pharma companies in 2015, they rose to 27 by 2020, an increase of 575 per cent in just six years.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page